You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

~ Buy the OMNARIS (ciclesonide) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR OMNARIS

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for OMNARIS

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00458835 ↗	Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)	Completed	AstraZeneca	Phase 4	2007-04-01	The purpose of this study is to compare the systemic des-ciclesonide exposure of OMNARIS™ (ciclesonide) nasal spray, ciclesonide HFA nasal aerosol, and orally inhaled ciclesonide HFA-metered-dose inhaler (MDI). The administration of the study medication will be as follows: three single doses, separated by a wash-out period. The study will provide further data on the safety and tolerability of ciclesonide.
NCT01033825 ↗	Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis	Completed	Sunovion	Phase 3	2010-01-01	To demonstrate the effects of ciclesonide applied as a nasal aerosol and ciclesonide aqueous (AQ) nasal spray on hypothalamic-pituitary-adrenal axis.
NCT01430260 ↗	Omnaris Versus Levocetirizine Phase 4 Study	Completed	Takeda	Phase 4	2011-01-01	This i a comparison of the efficacy ciclesonide nasal spray and levocetirizine, alone and in combination.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for OMNARIS

Condition Name

Chart
Table

Condition Name for OMNARIS
Intervention	Trials
Allergic Rhinitis	3
Perennial Allergic Rhinitis	2
Seasonal Allergic Rhinitis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for OMNARIS
Intervention	Trials
Rhinitis, Allergic	7
Rhinitis	7
Rhinitis, Allergic, Perennial	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for OMNARIS

Trials by Country

Map
Table

Trials by Country for OMNARIS
Location	Trials
United States	23
Canada	3
Korea, Republic of	1
Russian Federation	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for OMNARIS
Location	Trials
Texas	3
Pennsylvania	2
New Jersey	2
Minnesota	2
Massachusetts	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for OMNARIS

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for OMNARIS
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	3
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for OMNARIS
Clinical Trial Phase	Trials
Completed	7
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for OMNARIS

Sponsor Name

Chart
Table

Sponsor Name for OMNARIS
Sponsor	Trials
AstraZeneca	2
Sunovion	2
Takeda	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for OMNARIS
Sponsor	Trials
Industry	9
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.